27505 Bimekizumab short-term and longer-term anxiety, depression, and suicidal ideation/behavior in patients with moderate to severe plaque psoriasis: Analysis of pooled data from eight phase 2/3 clinical trials
Strober B, Papp K, Blauvelt A, Lebwohl M, Wu J, Deherder D, Madden C, Wixted K, Wang M, Augustin M. 27505 Bimekizumab short-term and longer-term anxiety, depression, and suicidal ideation/behavior in patients with moderate to severe plaque psoriasis: Analysis of pooled data from eight phase 2/3 clinical trials. Journal Of The American Academy Of Dermatology 2021, 85: ab149. DOI: 10.1016/j.jaad.2021.06.611.Peer-Reviewed Original Research